Novo Nordisk has signed a $2.1 billion licensing deal with biotechnology company Vivtex Corporation, in a bid to expand its oral biologic pipeline, which includes its blockbuster GLP-1 obesity therapy Wegovy (semaglutide)
The product may contain milk (including lactose), soy, peanuts, other nuts, sesame seeds, cereals containing gluten, eggs, crustaceans, fish
Musculoskeletal symptoms Endometriosis frequently involves lower back pain and body aches
Ethics declarations Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors
It will help you prepare and manage the side effects